Cristina Rondinone
Plus aucun poste en cours
Fortune : - $ au 31/12/2023
Profil
Cristina M.
Rondinone served as the President of Cellarity Inc. from 2019 to 2020.
Prior to that, she was the Senior Vice President of Research & Development at MedImmune LLC from 2011 to 2019.
She also served as an Independent Director at Axcella Health, Inc. from 2018 to 2023.
Before her industry roles, she was an Associate Professor at the University of Gothenburg.
Rondinone received her graduate and doctorate degrees from Universidad de Buenos Aires.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AXCELLA HEALTH, INC.
-.--% | 31/10/2023 | 0 ( -.--% ) | - $ | 31/12/2023 |
Anciens postes connus de Cristina Rondinone
| Sociétés | Poste | Fin |
|---|---|---|
| AXCA HEALPAR | Director/Board Member | 01/11/2023 |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | President | 01/06/2020 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/09/2019 |
| University of Gothenburg | Corporate Officer/Principal | - |
Formation de Cristina Rondinone
| Universidad de Buenos Aires | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AXCA HEALPAR | Health Technology |
| Entreprise privées | 2 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
